May 30, | nursing, med, NURS, Paper
Samantha Graves iHuman Problem Statement
Samantha Graves iHuman Problem Statement
Samantha is an 18 month old female with a two day history of diarrhea and vomiting. She has had 4-5 episodes of non-bilous emesis per day. She has also had 3 episodes of runny, watery stools per day. Her appetite has decreased but she has been tolerating small amounts of pedialyte and milk. She has had a slightly decreased amount of wet diapers. She has no signs of dehydration on physical exam and is alert and active.
ORDER HERE
Samantha is an 18 month old female with a two day history of diarrhea and vomiting. She has had 4-5 episodes of non-bilous emesis per day Samantha Graves iHuman Problem Statement . She has also had 3 episodes of runny, watery stools per day. Her appetite has decreased but she has been tolerating small amounts of pedialyte and milk. She has had a slightly decreased amount of wet diapers. She has no signs of dehydration on physical exam and is alert and active. Samantha Graves iHuman Problem Statement
Case Plan
Samantha has viral gastroenteritis with no signs of dehydration. It is reassuring that she is tolerating oral liquids. We would advise the parents on the anticipated benign course of the illness and that the symptoms should resolve in the next few days We would explain the signs of dehydration to the parents and instruct them to continue giving smail amounts of fluids regularly Samantha can continue an age appropriate diet as tolerated. Although the BRAT diet and a clear liquid diet have been recommended in the past, it is now recommended that children continue their regular diet as tolerated as the previous diets have been found to provide suboptimal nutrition. We would also advise the family to ensure proper hand washing at home and not share utensils or foods with each other to prevent the spread of infection Samantha Graves iHuman Problem Statement.
May 30, | nursing, med, NURS, Paper
Gastrointestinal Pharmacology
Unit 8: Gastrointestinal Pharmacology
Gastrointestinal Pharmacology
Gastrointestinal Pharmacology
Welcome to Unit 8 of Advanced Pharmacology
There are a wide variety of drugs used to treat gastrointestinal disorders. Several groups of drugs are used almost exclusively to treat GI conditions. Our focus will be primary care thus intravenous formulations will not be discussed. Clinical use and dosing of drugs will be the focus as with other units and include an emphasis on rational drug selection and patient education.
Primary care providers also see a variety of GI disorders, including gastroesophageal reflux disease and peptic ulcer disease. Over the past several years, over-the-counter medications have become available to treat these conditions. However, it is important to understand the underlying pathophysiology, and know when over-the-counter treatment is ineffective. Stepwise approaches to care and special population considerations will be discussed.
Unit Learning Objectives
Examine the principles of pathophysiology and therapeutics that direct the pharmacotherapeutic interventions affecting the gastrointestinal system (CLO 1)
Analyze the pharmacokinetic and pharmacodynamic actions of agents affecting the gastrointestinal system (CLO 2)
Apply critical-thinking processes to the management and evaluation of expected effects, potential adverse effects, and potential interactions of pharmacological agents affecting the gastrointestinal system (CLO 1,2)
Apply the evidence for pharmacotherapeutic interventions in a patient with gastrointestinal system disorders (CLO 1,2,3)
Evaluate the impact of pharmacogenomics, access, cost, quality, and safety on prescribing for Drugs Affecting the Gastrointestinal System (CLO 4)
Week 10/Unit 8 “To Do” List
Complete High-Yield Med Review Quiz by Sunday Week 10
Unit 6 & 7 Exam available Thursday 11/10 to Saturday 11/12 (Access via Respondus)
Learning Materials
Learning Materials
Lectures & E-Book
Busti, A. J. (2022). NP Curriculum Support-Advanced Pharmacology for NPs. MedEducation, LLC.
GASTROINTESTINAL PHARMACOLOGY
5-ASA Derivatives
Antacids
Antidiarrheals
Antiemetics
Fiber, laxatives, Stool Softeners
SPECIAL TOPICS IN PHARMACOLOGY
Drug Food Interactions
Drug Gastric Acid Interactions
Optional Learning Resources:
Media
Parkes, C. (2019a, June 26). Nursing pharmacology – H2 receptor antagonists, PPIs, sucralfate, antacids, prostaglandins [Video]. YouTube. https://www.youtube.com/watch?v=tYnSDaHQNhM
Parkes, C. (2019b, June 26). Nursing pharmacology – antiemetic, antidiarrhea medications and prokinetic agents [Video]. YouTube. https://www.youtube.com/watch?v=vmbfLsNbMpk
Websites
Khan Academy. (2018a). Advanced gastrointestinal physiology. Retrieved March 11, 2021, from https://www.khanacademy.org/science/health-and-medicine/gastro-intestinal-system
Khan Academy. (2018c). Gastrointestinal system diseases. Retrieved March 11, 2021, from https://www.khanacademy.org/science/health-and-medicine/gastrointestinal-system-diseases
HYMR Quiz – GI
Following review of all assigned lectures and correlating E-book chapters in High Yield Med Review, you will complete the module quiz in the HYMR platform.
From the Dashboard select “EXAMS”
Navigate to the “GI-Self Assessment”
Click “Take Exam”
You will have one attempt to complete 5 questions in 10 minutes. Once completed, please take a screen shot of your score and upload to this assignment tab for grading. This quiz is worth 20 points, so based on your % score you will receive the correlating points below.
100%
20 points
90%
18 points
80%
16 points
70%
14 points
60%
12 points
50%
10 points
40%
8 points
30%
6 points
20%
4 points
10%
2 points
No submission
0 points
*Please note, faculty are able to view your time and activity in HYMR.*
Unit Conclusion
Unit Conclusion
As we wrap up unit 8 of Advanced Pharmacology, we discussed the wide variety of drugs used to treat gastrointestinal disorders. We also learned in-depth treatment of GI disorders. Stepwise approaches to care and special population considerations are always important to remember when prescribing medications. Recall that rational drug selection emphasizes concentrating on resolving or treating the underlying disease state while reducing side effects.
